MREO (MREO) Stock Price & Analysis
MREO (MREO) fell 8.16% to USD 0.25 as of September 8, 2026 at 07:37 UTC, according to Nexqual real-time market data.
MREO last closed at USD 0.25; the session ranged USD 0.25–0.27 on volume of 1,338,932 shares. Market capitalization is —, with a 52-week range of USD 0.2–2.37 (NCM). Source: Nexqual, September 8, 2026 at 07:37 UTC.
Key Statistics (as of September 8, 2026 at 07:37 UTC)
| Price | USD 0.25 |
|---|---|
| Change | ▼ 8.16% (down) |
| Previous Close | USD 0.25 |
| Open | USD 0.25 |
| Day Range | USD 0.25 – 0.27 |
| 52-Week Range | USD 0.2 – 2.37 |
| Volume | 1,338,932 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (MREO)
Nexqual's technical model rates MREO "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 07:37 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 37 (neutral) |
| vs SMA50 | Below (USD 0.3) |
| MACD | -0.01 (negative) |
From MREO's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PDSB | PDS Biotechnology Corporation | USD 0.22 | ▲ 3.77% |
| CYPH | Cypherpunk Technologies Inc. | USD 2.42 | ▲ 44.05% |
| ABEO | Abeona Therapeutics Inc. | USD 6 | ▲ 0.84% |
| PAVM | PAVmed Inc. | USD 5.28 | ▼ 1.31% |
| CRVS | Corvus Pharmaceuticals, Inc. | USD 14.39 | ▲ 1.34% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:37 UTC. This page is informational and not investment advice.